DUBLIN--(BUSINESS WIRE)--Jun. 17, 2013-- Elan Corporation, plc (NYSE:ELN) (Elan or the Company) announces that, at its Extraordinary General Meeting held earlier today, shareholders approved the Share ...

Elan Corporation, plc (ELN) (Elan or the Company) today announced that it is proceeding with a formal sale process in light of the expressions of interest received to date. As part of this process, ...

DUBLIN--(BUSINESS WIRE)--The Board of Elan Corporation, plc (NYSE : ELN) (Elan) notes this morning’s announcement regarding the offer by Echo Pharma Acquisition Limited (“Royalty Pharma”) to acquire ...

SAN FRANCISCO & NEW YORK & DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) announced today that Renee P. Tannenbaum, Pharm.D., has joined the company as Executive Vice President and Chief ...

Elan is a biotechnology company, headquartered in Ireland, committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill ...

DUBLIN--(BUSINESS WIRE)-- Elan Corporation, plc (NYS: ELN) today issued a formal response document in respect of the Echo Pharma Acquisition Limited (Royalty Pharma) revised offer made on May 23, 2013 ...